Skip to main content
. 2016 Apr 28;11(6):4240–4244. doi: 10.3892/ol.2016.4508

Figure 5.

Figure 5.

Echocardiography and ECG examinations performed following erlotinib treatment. (A) ECG performed on May 15, 2014, following targeted treatment. (B) Echocardiography performed on May 19, 2014, following 1 month of targeted treatment. ECG, electrocardiogram.